These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 22792369

  • 1. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.
    Ferrer IR, Wagener ME, Song M, Ford ML.
    PLoS One; 2012; 7(7):e40559. PubMed ID: 22792369
    [Abstract] [Full Text] [Related]

  • 2. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL.
    J Immunol; 2000 Jan 01; 164(1):512-21. PubMed ID: 10605049
    [Abstract] [Full Text] [Related]

  • 3. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y, Meng L, Busuttil RW, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 2003 Mar 15; 170(6):3024-8. PubMed ID: 12626556
    [Abstract] [Full Text] [Related]

  • 4. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY, Lee EN, Lee J, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Joh JW, Kim SJ.
    Exp Mol Med; 2006 Jun 30; 38(3):284-94. PubMed ID: 16819287
    [Abstract] [Full Text] [Related]

  • 5. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z, Wang Y, Gao F, Shen X, Zhai Y, Kupiec-Weglinski JW.
    J Immunol; 2008 Jul 15; 181(2):1096-102. PubMed ID: 18606661
    [Abstract] [Full Text] [Related]

  • 6. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW.
    J Immunol; 2002 Oct 15; 169(8):4667-73. PubMed ID: 12370407
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of donor-specific transfusion sources: unique failure of bone marrow cells to induce prolonged skin allograft survival with anti-CD154 monoclonal antibody.
    Markees TG, Pearson T, Cuthbert A, Pearson AL, Shultz LD, Leif J, Phillips NE, Mordes JP, Greiner DL, Rossini AA.
    Transplantation; 2004 Dec 15; 78(11):1601-8. PubMed ID: 15591948
    [Abstract] [Full Text] [Related]

  • 8. Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.
    Ji H, Shen XD, Gao F, Busuttil RW, Zhai Y, Kupiec-Weglinski JW.
    Transplantation; 2011 May 27; 91(10):1075-81. PubMed ID: 21427633
    [Abstract] [Full Text] [Related]

  • 9. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
    Chen Y, Heeger PS, Valujskikh A.
    J Immunol; 2004 May 01; 172(9):5456-66. PubMed ID: 15100287
    [Abstract] [Full Text] [Related]

  • 10. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ, Markees TG, Phillips NE, Appel MC, Cuthbert A, Leif J, Mordes JP, Shultz LD, Rossini AA, Greiner DL.
    Transplantation; 2004 Sep 15; 78(5):660-7. PubMed ID: 15371665
    [Abstract] [Full Text] [Related]

  • 11. Defective alloreactive CD8 T cell function and memory response in allograft recipients in the absence of CD4 help.
    Zhai Y, Wang Y, Wu Z, Kupiec-Weglinski JW.
    J Immunol; 2007 Oct 01; 179(7):4529-34. PubMed ID: 17878349
    [Abstract] [Full Text] [Related]

  • 12. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ, Blazar BR, Adeyi OA, Strom TB, Noelle RJ.
    Transplantation; 2003 Nov 15; 76(9):1375-9. PubMed ID: 14627918
    [Abstract] [Full Text] [Related]

  • 13. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB, Brehm MA, Markees TG, Shultz LD, Mordes JP, Welsh RM, Rossini AA, Greiner DL.
    J Immunol; 2006 Feb 01; 176(3):1561-70. PubMed ID: 16424185
    [Abstract] [Full Text] [Related]

  • 14. Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade.
    Turgeon NA, Iwakoshi NN, Phillips NE, Meyers WC, Welsh RM, Greiner DL, Mordes JP, Rossini AA.
    J Surg Res; 2000 Sep 01; 93(1):63-9. PubMed ID: 10945944
    [Abstract] [Full Text] [Related]

  • 15. Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.
    Xu H, Yan J, Huang Y, Chilton PM, Ding C, Schanie CL, Wang L, Ildstad ST.
    Blood; 2008 Mar 15; 111(6):3266-75. PubMed ID: 17827394
    [Abstract] [Full Text] [Related]

  • 16. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.
    Burns AM, Chong AS.
    J Immunol; 2011 Jan 01; 186(1):214-21. PubMed ID: 21135169
    [Abstract] [Full Text] [Related]

  • 17. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade.
    Wang Y, Dai H, Liu Z, Cheng X, Tellides G, Dai Z.
    Am J Transplant; 2006 Dec 01; 6(12):2851-60. PubMed ID: 17062001
    [Abstract] [Full Text] [Related]

  • 18. High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade.
    Floyd TL, Orr SB, Coley SM, Hanna SS, Wagener ME, Kirk AD, Larsen CP, Ford ML.
    Transplantation; 2010 May 27; 89(10):1208-17. PubMed ID: 20407401
    [Abstract] [Full Text] [Related]

  • 19. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN, Markees TG, Turgeon N, Thornley T, Cuthbert A, Leif J, Phillips NE, Mordes JP, Greiner DL, Rossini AA.
    J Immunol; 2001 Dec 01; 167(11):6623-30. PubMed ID: 11714833
    [Abstract] [Full Text] [Related]

  • 20. An anti-CD154 domain antibody prolongs graft survival and induces Foxp3(+) iTreg in the absence and presence of CTLA-4 Ig.
    Pinelli DF, Wagener ME, Liu D, Yamniuk A, Tamura J, Grant S, Larsen CP, Suri A, Nadler SG, Ford ML.
    Am J Transplant; 2013 Nov 01; 13(11):3021-30. PubMed ID: 24007441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.